Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary

Nicholas K. Larsen; Matthew J. Reilly; Seunghyug Kwon; Brian W. Loggie; Marcus W. Balters

doi:10.1016/j.gore.2020.100638

Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary

Nicholas K. Larsen, Matthew J. Reilly, Seunghyug Kwon, Brian W. Loggie, Marcus W. Balters

Department of Surgery

Research output: Contribution to journal › Article › peer-review

Abstract

Sertoli Leydig cell tumor (SLCT) is a rare sex-cord stromal tumor of the ovary that generally has a benign course. Here, we report an unusual case of recurrent, metastatic SLCT and its unique management with a combination of cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, hyperthermic intrathoracic chemotherapy, and systemic chemotherapy.

Original language	English (US)
Article number	100638
Journal	Gynecologic Oncology Reports
Volume	34
DOIs	https://doi.org/10.1016/j.gore.2020.100638
State	Published - Nov 2020

All Science Journal Classification (ASJC) codes

Oncology
Obstetrics and Gynecology

Access to Document

10.1016/j.gore.2020.100638

Fingerprint Dive into the research topics of 'Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary'. Together they form a unique fingerprint.

Cite this

@article{d8fe5a58ac184fd3abb486656787977f,

title = "Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary",

abstract = "Sertoli Leydig cell tumor (SLCT) is a rare sex-cord stromal tumor of the ovary that generally has a benign course. Here, we report an unusual case of recurrent, metastatic SLCT and its unique management with a combination of cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, hyperthermic intrathoracic chemotherapy, and systemic chemotherapy.",

author = "Larsen, {Nicholas K.} and Reilly, {Matthew J.} and Seunghyug Kwon and Loggie, {Brian W.} and Balters, {Marcus W.}",

year = "2020",

month = nov,

doi = "10.1016/j.gore.2020.100638",

language = "English (US)",

volume = "34",

journal = "Gynecologic Oncology Reports",

issn = "2211-338X",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary

AU - Larsen, Nicholas K.

AU - Reilly, Matthew J.

AU - Kwon, Seunghyug

AU - Loggie, Brian W.

AU - Balters, Marcus W.

PY - 2020/11

Y1 - 2020/11

N2 - Sertoli Leydig cell tumor (SLCT) is a rare sex-cord stromal tumor of the ovary that generally has a benign course. Here, we report an unusual case of recurrent, metastatic SLCT and its unique management with a combination of cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, hyperthermic intrathoracic chemotherapy, and systemic chemotherapy.

AB - Sertoli Leydig cell tumor (SLCT) is a rare sex-cord stromal tumor of the ovary that generally has a benign course. Here, we report an unusual case of recurrent, metastatic SLCT and its unique management with a combination of cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, hyperthermic intrathoracic chemotherapy, and systemic chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=85091029543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091029543&partnerID=8YFLogxK

U2 - 10.1016/j.gore.2020.100638

DO - 10.1016/j.gore.2020.100638

M3 - Article

AN - SCOPUS:85091029543

VL - 34

JO - Gynecologic Oncology Reports

JF - Gynecologic Oncology Reports

SN - 2211-338X

M1 - 100638

ER -

Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this